Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/136286
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies |
Author: | Lalor, A.F. Brooker, J.E. Rozbroj, T. Whittle, S.L. Hill, C.L. Rowett, D. Buchbinder, R. O'Connor, D.A. |
Citation: | Seminars in Arthritis and Rheumatism, 2022; 55:151988-1-151988-13 |
Publisher: | Elsevier BV |
Issue Date: | 2022 |
ISSN: | 0049-0172 1532-866X |
Statement of Responsibility: | Aislinn F. Lalora, Joanne E. Brooker, Tomas Rozbroj, Samuel L. Whittle, Catherine L. Hill, Debra Rowetth, Rachelle Buchbinder, Denise A. O, Connor |
Abstract: | Abstract not available |
Keywords: | Rheumatoid arthritis; Qualitative thematic synthesis; DMARDs, Disease-modifying anti-rheumatic drugs; csDMARDs, Conventional disease-modifying anti-rheumatic drugs; tsDMARDs, Targeted synthetic disease-modifying anti-rheumatic drugs; bDMARDs, Biologic disease-modifying antirheumatic drugs; RA, Rheumatoid arthritis; PsA, Psoriatic arthritis; Axial SpA, Axial spondyloarthritis; Qualitative metasummary; Biologic therapies |
Rights: | © 2022 Elsevier Inc. All rights reserved. |
DOI: | 10.1016/j.semarthrit.2022.151988 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1194483 http://purl.org/au-research/grants/nhmrc/1168749 |
Published version: | http://dx.doi.org/10.1016/j.semarthrit.2022.151988 |
Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.